BCRX
Biocryst Pharm (BCRX)
NASDAQ
$7.62+$0.08 (+1.13%)
Price as of Nov 11, 2026 7:50 PM EST
  • $1.9B
    Market Cap
  • 4.15%
    1-Year Change
  • Drug Manufacturers - Specialty & Generic
    Industry

Earnings Score

Score: 42
Valuation
BCRX
vs History
vs S&P 500
Profitability
-0
Growth
-0
Low Earnings Volatility
2

Momentum Score

Score: 50
Valuation
BCRX
vs History
vs S&P 500
3-Month Momentum
-15.04%
12-Month Momentum
16.11%
3-Month Risk Adjusted Momentum
-77.25%
12-Month Risk Adjusted Momentum
34.82%

True Yield

N/A
Valuation
BCRX
vs History
vs S&P 500
Dividend Yield
N/A
Net Buyback Yield
-1.44%
Net Debt Paydown Yield
-0.01%

Financial Health Score

Score: 41
Valuation
BCRX
vs History
vs S&P 500
Ohlson's O-Score
2